Logo
homeHome
toggle_offCompany ProfilegroupsBoards & Staffsworkspace_premiumMemberships & PartnersschoolAcademy of Journalismperson_addCareerslinkBlog(EN)emailContact Us
list_altOur JournalslightbulbInstruction for AuthorsbookmarkBrieflands PolicieshandshakePublish My Researchplay_circleJournal Management Systemcredit_cardArticle Processing Chargeszoom_inOpen Peer ReviewimagePublishing Services
menu_bookPublish My Book
  1. Brieflands
  2. journals
  3. International Journal of Cardiovascular Practice
  4. Articles

  5. Short-term Cost-effectiveness of Reteplase versus Primary Percutaneous Coronary Intervention in Patients with Acute STEMI a Tertiary Hospital in Iran
  6. Crossref

International Journal of Cardiovascular Practice

homeHome
format_indent_increaseCurrent IssuelistAll Issuesplay_arrowIn Presscheck_circleAccepted ManuscriptssearchSearch
lightbulbInstructions
monitor_heartJournal InformationgroupsEditors & BoardspublicIndexing and Listing Sourcesbar_chartJournal Metricszoom_inOpen Peer Review (OPR)balancePublication Ethics and Malpractice Statementassignment_indReviewer and AE Registration FormemailSupportphoneContact Us
Authors GuideSubmit Manuscript

Crossref


1. Treatment selection factors and outcome comparison in acute myocardial infarction

- Elham Gholamian

- Nasrin Hanifi

- Parvin Shiri Qidari

2. Short-and Long–Term Follow–up in the Elderly Patients With ST–Elevation Myocardial Infarction Receiving Primary Angioplasty or Thrombolytic Therapy

- Mohammad Kazem Kazemi

- Khalil Alimohammadzadeh

- Ali Maher

HomeInstructions

Archives

  • Current Issue
  • All Issues
  • In Press
  • Accepted Manuscripts
  • Search

About Journal

  • Journal Information
  • Editors & Boards
  • Indexing and Listing Sources
  • Journal Metrics
  • Open Peer Review (OPR)
  • Publication Ethics and Malpractice Statement
  • Reviewer and AE Registration Form
  • Support
  • Contact Us
Support
Submit a Ticket
BrieflandsBrieflands

Science, Technical, Medical Publisher, Since 2007

All rights reserved by Brieflands, 2026.

Powered by Neoscriber.